Search Results

There are 13950 results for: content related to: Comparative Cardiovascular Safety of Dementia Medications: A Cross-National Study

  1. Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment

    International Journal of Clinical Practice

    Volume 60, Issue 1, January 2006, Pages: 110–118, T. Dantoine, 1 S. Auriacombe, 2 M. Sarazin, 3 H. Becker, 4 J-J Pere and 5 I. Bourdeix 5

    Version of Record online : 20 DEC 2005, DOI: 10.1111/j.1368-5031.2005.00769.x

  2. You have free access to this content
    The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease

    CNS Drug Reviews

    Volume 9, Issue 3, September 2003, Pages: 275–308, Michael A. Rogawski and Gary L. Wenk

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2003.tb00254.x

  3. Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies

    Drug Development Research

    Volume 64, Issue 1, January 2005, Pages: 71–81, Ramesh C. Gupta and A. Dekundy

    Version of Record online : 19 APR 2005, DOI: 10.1002/ddr.10422

  4. Pharmacological Therapies in Alzheimer's Disease

    Principles and Practice of Geriatric Psychiatry, Third Edition

    Martin Steinberg, Constantine G. Lyketsos, Pages: 304–311, 2010

    Published Online : 8 DEC 2010, DOI: 10.1002/9780470669600.ch52

  5. You have free access to this content
    Memantine binding to a superficial site on NMDA receptors contributes to partial trapping

    The Journal of Physiology

    Volume 587, Issue 19, October 2009, Pages: 4589–4604, Shawn E. Kotermanski, Jesse T. Wood and Jon W. Johnson

    Version of Record online : 29 SEP 2009, DOI: 10.1113/jphysiol.2009.176297

  6. The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis

    International Journal of Geriatric Psychiatry

    Volume 19, Issue 10, October 2004, Pages: 919–925, Gill Livingston and Cornelius Katona

    Version of Record online : 27 SEP 2004, DOI: 10.1002/gps.1166

  7. Rationale for Combination Therapy With Galantamine and Memantine in Alzheimer's Disease

    The Journal of Clinical Pharmacology

    Volume 46, Issue S1, July 2006, Pages: 17S–26S, Dr George T. Grossberg, Dr Keith R. Edwards and Dr Qinying Zhao

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006288735

  8. Memantine for dementia

    Intervention Review

    The Cochrane Library

    Rupert McShane, Almudena Areosa Sastre and Neda Minakaran

    Published Online : 19 APR 2006, DOI: 10.1002/14651858.CD003154.pub5

  9. You have free access to this content
    Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine – searching for the connections

    British Journal of Pharmacology

    Volume 167, Issue 2, September 2012, Pages: 324–352, Wojciech Danysz and Chris G Parsons

    Version of Record online : 22 AUG 2012, DOI: 10.1111/j.1476-5381.2012.02057.x

  10. Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application

    ELECTROPHORESIS

    Volume 31, Issue 11, June 2010, Pages: 1903–1911, Hsin-Hua Yeh, Yuan-Han Yang and Su-Hwei Chen

    Version of Record online : 5 MAY 2010, DOI: 10.1002/elps.201000001

  11. You have free access to this content
    Posters Session 1, Sunday 18 September

    European Journal of Neurology

    Volume 12, Issue s2, September 2005, Pages: 37–300,

    Version of Record online : 6 SEP 2005, DOI: 10.1111/j.1468-1331.2005.01308.x

  12. Steady-State Pharmacokinetics of Galantamine Are Not Affected by Addition of Memantine in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 519–528, Dr Caiping Yao, Dr Arash Raoufinia, Dr Michael Gold, Dr Jeffrey S. Nye, Dr Steven Ramael, Mr Mukund Padmanabhan, Dr Yolande Walschap, Dr Tom Verhaeghe and Dr Qinying Zhao

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005274551

  13. You have free access to this content
    EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

    European Journal of Neurology

    Volume 22, Issue 6, June 2015, Pages: 889–898, R. Schmidt, E. Hofer, F. H. Bouwman, K. Buerger, C. Cordonnier, T. Fladby, D. Galimberti, J. Georges, M. T. Heneka, J. Hort, J. Laczó, J. L Molinuevo, J. T. O'Brien, D. Religa, P. Scheltens, J. M. Schott and S. Sorbi

    Version of Record online : 25 MAR 2015, DOI: 10.1111/ene.12707

  14. You have free access to this content
    Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism.

    The Journal of Physiology

    Volume 499, Issue 1, February 15, 1997, Pages: 27–46, H S Chen and S A Lipton

    Version of Record online : 15 FEB 1997, DOI: 10.1113/jphysiol.1997.sp021909

  15. Memantine reduces alcohol drinking but not relapse in alcohol-dependent rats

    Addiction Biology

    Volume 20, Issue 5, September 2015, Pages: 890–901, Stéphanie Alaux-Cantin, Romain Buttolo, Hakim Houchi, Jérôme Jeanblanc and Mickaël Naassila

    Version of Record online : 20 AUG 2014, DOI: 10.1111/adb.12177

  16. You have free access to this content
    Poster session 1

    European Journal of Neurology

    Volume 14, Issue s1, August 2007, Pages: 32–163,

    Version of Record online : 3 SEP 2007, DOI: 10.1111/j.1468-1331.2007.01936.x

  17. You have free access to this content
    Effects of the Non-Competitive NMDA Receptor Antagonist Memantine on the Volitional Consumption of Ethanol by Alcohol-Preferring Rats

    Basic & Clinical Pharmacology & Toxicology

    Volume 106, Issue 5, May 2010, Pages: 435–444, Gloria E. Malpass, Helen L. Williams and Brian A. McMillen

    Version of Record online : 22 FEB 2010, DOI: 10.1111/j.1742-7843.2010.00544.x

  18. You have free access to this content
    MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway

    British Journal of Pharmacology

    Volume 172, Issue 9, May 2015, Pages: 2354–2368, Guoqi Zhu, Junyao Li, Ling He, Xuncui Wang and Xiaoqi Hong

    Version of Record online : 26 MAR 2015, DOI: 10.1111/bph.13061

  19. Memantine lowers amyloid-β peptide levels in neuronal cultures and in APP/PS1 transgenic mice

    Journal of Neuroscience Research

    Volume 88, Issue 1, January 2010, Pages: 143–154, George M. Alley, Jason A. Bailey, DeMao Chen, Balmiki Ray, Lakshman K. Puli, Heikki Tanila, Pradeep K. Banerjee and Debomoy K. Lahiri

    Version of Record online : 29 JUL 2009, DOI: 10.1002/jnr.22172

  20. You have free access to this content
    Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

    British Journal of Pharmacology

    Volume 117, Issue 4, February 1996, Pages: 689–697, Tadeusz Frankiewicz, Brigitte Potier, Zafar I. Bashir, Graham L. Collingridge and Chris G. Parsons

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1996.tb15245.x